Reneo Pharmaceuticals, Inc. (RPHM) - Quarterly Income Statement

Home
RPHM
Financials

18.2 (USD) • At close October 4, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	-0.734	0	0	0	0.734	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.072	0	0	0.016	0.044	0.043	0.163	0.161	0.128	0.119	0.022	0.019	0.017	0.013	0.01	0.01	0	0	0	0
Gross Profit Numbers are in millions	0	-0.662	0	-0.012	-0.016	0.69	-0.043	-0.163	-0.161	-0.128	-0.119	-0.022	-0.019	-0.017	-0.013	-0.01	-0.01	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0.902	0	0	0	0.94	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	13.012	20.731	0.904	0.59	4.926	17.56	13.622	14.4	10.991	10.357	9.938	8.132	9.278	7.1	9.318	6.279	5.472	5.118	4.431	2.817	3.578
General & Administrative Expenses Numbers are in millions	3.988	7.207	3.76	5.774	4.622	7.402	7.266	6.639	5.132	4.205	3.902	4.299	3.737	3.524	3.434	2.949	1.742	1.133	0.668	0.882	0.924
Selling & Marketing Expenses Numbers are in millions	0	-1.062	0	0	0	1.062	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	3.988	8.269	3.76	5.774	4.622	8.464	7.266	6.639	5.132	4.205	3.902	4.299	3.737	3.524	3.434	2.949	1.742	1.133	0.668	0.882	0.924
Other Expenses Numbers are in millions	0	-3.593	0	0	1.138	1.452	1.692	1.508	1.016	0.962	0.833	0.119	-0.021	0.017	0.017	0.012	0.002	-0.002	0.005	0.012	0.071
Operating Expenses Numbers are in millions	17	29	4.664	6.364	9.548	26.024	20.888	21.039	16.123	14.562	13.84	12.431	13.015	10.624	12.752	9.228	7.214	6.251	5.099	3.699	4.502
Operating Income Numbers are in millions	-17	-12.39	-4.664	-6.364	-9.564	-26.068	-20.888	-21.039	-16.123	-14.562	-13.84	-12.431	-13.015	-10.624	-12.752	-9.228	-7.214	-6.251	-5.099	-3.699	-4.502
Operating Income Ratio Numbers are in millions	0	16.88	0	0	0	-35.515	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0	49.731	0.972	1.003	1.138	1.452	1.692	1.508	1.016	0.962	0.833	0.119	-0.021	0.017	0.017	0.012	0.002	-0.002	0.005	0.012	0.071
Income Before Tax Numbers are in millions	0	37.341	-3.692	-5.361	-8.426	-23.554	-19.196	-19.531	-15.107	-13.6	-13.007	-12.312	-13.036	-10.607	-12.735	-9.216	-7.212	-6.253	-5.094	-3.687	-4.431
Income Before Tax Ratio Numbers are in millions	0	-50.873	0	0	0	-32.09	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	-1.032	0	0	-0.027	1.059	-0.043	-0.08	-1.016	-0.962	-0.833	0	0.021	-0.017	-0.034	-0.012	-0.002	0.004	-0.01	-0.012	-0.071
Net Income Numbers are in millions	0	37.341	-3.692	-5.361	-8.426	-23.554	-19.196	-19.531	-14.091	-12.638	-12.174	-12.312	-13.057	-10.607	-12.735	-9.216	-7.212	-6.253	-5.094	-3.687	-4.431
Net Income Ratio Numbers are in millions	0	-50.873	0	0	0	-32.09	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-1.19	-14.17	-1.1	-0.16	-0.25	-0.7	-0.57	-0.65	-0.56	-0.52	-0.5	-0.5	-0.53	-0.43	-0.52	-0.43	-0.3	-0.26	-0.65	-0.47	-0.57
EPS Diluted Numbers are in millions	-1.19	-14.17	-1.1	-0.16	-0.25	-0.7	-0.57	-0.65	-0.56	-0.52	-0.5	-0.5	-0.53	-0.43	-0.52	-0.43	-0.3	-0.26	-0.65	-0.47	-0.57
EBITDA Numbers are in millions	-17	35.937	-4.664	-6.352	-9.548	-26.024	-20.845	-20.997	-16.082	-14.434	-13.818	-12.409	-12.996	-10.607	-12.739	-9.218	-7.204	-6.241	-5.09	-3.69	-4.493
EBITDA Ratio Numbers are in millions	0	-48.961	0	0	0	-35.455	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Reneo Pharmaceuticals, Inc.

NASDAQ:RPHM Add to watchlist

NASDAQ:RPHM